SFB 432: Mechanismen der Tumorabwehr und ihre therapeutische Beeinflussung
Forschungsverbund / Johannes Gutenberg-Universität Mainz
Blank, C; Kuball, J; Voelkl, S et al.
Blockade of PD-L1 (B7-H1) augments human tumor-specific T cell responses in vitro.Int J Cancer. Bd. 119. H. 2. 2006 S. 317-27
Christmann, M; Tomicic, MT; Origer, D et al.
c-Fos is required for excision repair of UV-light induced DNA lesions by triggering the resynthesis of XPFNucleic Acids Res. Bd. 34. 2006 S. 6530-6539
Simon, CO; Holtappels, R; Tervo, HM et al.
CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivation.J Virol. Bd. 80. H. 21. 2006 S. 10436-56
Holtappels, R; Munks, MW; Podlech, J et al.
CD8 T-cell-based immunotherapy of cytomegalovirus disease in the mouse model of the immunocompromised bone marrow transplantation recipientM. J. Reddehase (ed.), Cytomegaloviruses: molecular biology and immunology. 1. Aufl. Wymondham, Norfolk, United Kingdom: Caister Academic Press 2006
Kiesslich, R; Hoffman, A; Neurath, MF
Colonoscopy, tumors, and inflammatory bowel disease - new diagnostic methods.Endoscopy. Bd. 38. H. 1. 2006 S. 5-10
Holtappels, R; Gillert-Marien, D; Thomas, D et al.
Cytomegalovirus encodes a positive regulator of antigen presentation.J Virol. Bd. 80. H. 15. 2006 S. 7613-24
Pepperl-Klindworth, S; Besold, K; Frankenberg, N et al.
Cytomegalovirus Interleukin-10 Expression in Infected Cells Does Not Impair MHC Class I Restricted Peptide Presentation on Bystanding Antigen-Presenting CellsViral Immunol. Bd. 19. H. 1. 2006 S. 92-101
Schadendorf, D; Ugurel, S; Schuler-Thurner, B et al.
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.Ann Oncol. Bd. 17. 2006 S. 563-570
Hartwig, UF; Nonn, M; Khan, S et al.
Depletion of alloreactive T cells via CD69: implications on antiviral, antileukemic and immunoregulatory T lymphocytes.Bone Marrow Transpl. Bd. 37. H. 3. 2006 S. 297-305
Roos, WP; Kaina, B
DNA damage-induced cell death by apoptosisTrends in Molecular Medicine. Bd. 12. H. 9. 2006 S. 440-450
Steitz, J; Britten, CM; Wolfel, T et al.
Effective induction of anti-melanoma immunity following genetic vaccination with synthetic mRNA coding for the fusion protein EGFP.TRP2.Cancer Immunol Immunother. Bd. 55. H. 3. 2006 S. 246-53
Steitz, J; Buchs, S; Tormo, D et al.
Evaluation of genetic melanoma vaccines in cdk4-mutant mice provides evidence for immunological tolerance against authochthonous melanomas in the skin.Int J Cancer. Bd. 118. H. 2. 2006 S. 373-80
Kuphal, S; Wallner, S; Schimanski, CC et al.
Expression of Hugl-1 is strongly reduced in malignant melanoma.Oncogene. Bd. 25. H. 1. 2006 S. 103-10
Grunwald, C; Koslowski, M; Arsiray, T et al.
Expression of multiple epigenetically regulated cancer/germline genes in nonsmall cell lung cancer.Int J Cancer. Bd. 118. H. 10. 2006 S. 2522-8
Klamp, T; Sahin, U; Kyewski, B et al.
Expression profiling of autoimmune regulator AIRE mRNA in a comprehensive set of human normal and neoplastic tissues.Immunol Lett. Bd. 106. H. 2. 2006 S. 172-9
Tureci, O; Mack, U; Luxemburger, U et al.
Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1.Cancer Lett. Bd. 236. H. 1. 2006 S. 64-71
Wu, J; Helftenbein, G; Koslowski, M et al.
Identification of new claudin family members by a novel PSI-BLAST based approach with enhanced specificity.Proteins. Bd. 65. H. 4. 2006 S. 808-15
Tüttenberg, A; Becker, C; Hüter, E et al.
Induction of strong and persistent MelanA/MART-1-specific immune responses by adjuvant dendritic cell-based vaccination of stage II melanoma patients.Int J Cancer. Bd. 118. 2006 S. 2617-2627
Bornhauser, M; Thiede, C; Babatz, J et al.
Infusion of bcr/abl peptide-reactive donor T cells to achieve molecular remission of chronic myeloid leukemia after CD34+ selected allogeneic hematopoietic cell transplantation.Leukemia. Bd. 20. H. 11. 2006 S. 2055-7
Erlach, KC; Böhm, V; Seckert, CK et al.
Lymphoma cell apoptosis in the liver induced by distant murine cytomegalovirus infection.J Virol. Bd. 80. H. 10. 2006 S. 4801-19
Holtkamp, S; Kreiter, S; Selmi, A et al.
Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells.Blood. Bd. 108. H. 13. 2006 S. 4009-17
Su, Z; Kuball, J; Barreiros, AP et al.
Nitric oxide promotes resistance to tumor suppression by CTLs.J Immunol. Bd. 176. H. 7. 2006 S. 3923-30
Chromik, J; Schnurer, E; Meyer, RG et al.
Proteasome-inhibited dendritic cells demonstrate improved presentation of exogenous synthetic and natural HLA-class I peptide epitopes.J Immunol Methods. Bd. 308. H. 1-2. 2006 S. 77-89
Sahin, U; Tureci, O; Graf, C et al.
Rapid molecular dissection of viral and bacterial immunomes.Eur J Immunol. Bd. 36. H. 4. 2006 S. 1049-57
Voss, RH; Kuball, J; Engel, R et al.
Redirection of T cells by delivering a transgenic mouse-derived MDM2 tumor antigen-specific TCR and its humanized derivative is governed by the CD8 coreceptor and affects natural human TCR expression.Immunol Res. Bd. 34. H. 1. 2006 S. 67-87